Almaziny MA-I (2014) Isolation, identification, and profile of antibiotic resistance of bacteria inchildhood febrile neutropenia patients. European. J Exp Biol 4
Al-Sweedan S, Hayajneh W, Al-Ostath A (2012) Patterns of bacteremia in cancer patient with febrile neutropenia at King Abdullah University Hospital – Jordan 2003 - 2008. J Pediatr Infect Dis 7:15–20. https://doi.org/10.3233/JPI-2012-0343
Al-Tawfiq JA, Hinedi K, Khairallah H, Saadeh B, Abbasi S, Noureen M, Raza S, Alkhatti A (2019) Epidemiology and source of infection in patients with febrile neutropenia: A ten-year longitudinal study. J Infect Public Health 12(3):364–366. https://doi.org/10.1016/j.jiph.2018.12.006
Ariffin H, Navaratnam P, Lin HP (2002) Surveillance study of bacteraemic episodes in febrile neutropenic children. Int J Clin Pract 56(4):237–240
Article PubMed CAS Google Scholar
Aslan S, Citak EC, Yis R, Degirmenci S, Arman D (2012) Bacterial spectrum and antimicrobial susceptibility pattern of bloodstream infections in children with febrile neutropenia: experience of single center in southeast of Turkey. Indian J Microbiol 52(2):203–208. https://doi.org/10.1007/s12088-011-0210-6
Article PubMed CAS Google Scholar
Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64(2):328–340. https://doi.org/10.7326/0003-4819-64-2-328
Article PubMed CAS Google Scholar
Cherif H, Johansson E, Björkholm M, Kalin M (2006) The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies. Haematologica 91(2):215–222
Crawford J, Dale DC, Lyman GH (2004) Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 100(2):228–237. https://doi.org/10.1002/cncr.11882
de la Court JR, Heijmans J, Huynh J, Sieswerda E, de Jonge NA, van Dijk K, Sigaloff KCE, Schade RP (2022) Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort study. Antimicrob Resist Infect Control 11(1):160. https://doi.org/10.1186/s13756-022-01198-5
Article PubMed PubMed Central Google Scholar
Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young J-AH, Wingard JR (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious Diseases Society of America. Clin Infect Dis 52(4):e56–e93. https://doi.org/10.1093/cid/cir073
González-Barca E, Fernández-Sevilla A, Carratalá J, Grañena A, Gudiol F (1996) Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis 15(4):291–296. https://doi.org/10.1007/BF01695660
Greenberg D, Moser A, Yagupsky P, Peled N, Hofman Y, Kapelushnik J, Leibovitz E (2005) Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols. Int J Antimicrob Agents 25(6):469–473. https://doi.org/10.1016/j.ijantimicag.2005.01.020
Article PubMed CAS Google Scholar
Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH (2009) Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 31(9):623–629. https://doi.org/10.1097/MPH.0b013e3181b1edc6
Article PubMed PubMed Central Google Scholar
Huang K-P, Wang T-F, Chu S-C, Wu Y-F, Wang R-Y, Kao R-H (2011) Analysis of pathogens and susceptibility in cancer patients with febrile neutropenia and bacteremia: Experience in a single institution in eastern Taiwan. Tzu Chi Med J 23(4):115–118. https://doi.org/10.1016/j.tcmj.2011.09.002
Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KVI, Shenep JL, Young LS (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34(6):730–751. https://doi.org/10.1086/339215
Jamal A, Fatima N, Shaikh S, Kaleem B, Rizvi QA, Zaidi U, Borhany M, Shamsi T (2019) Pattern of antimicrobial sensitivity in microbiologically documented infections in neutropenic patients with haematological malignancies: a single center study. Indian J Microbiol 59(2):188–192. https://doi.org/10.1007/s12088-019-00789-y
Article PubMed PubMed Central CAS Google Scholar
Joudeh N, Sawafta E, Abu Taha A, Hamed Allah M, Amer R, Odeh RY, Salameh H, Sabateen A, Aiesh BM, Zyoud SH (2023) Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country. BMC Infect Dis 23(1):106. https://doi.org/10.1186/s12879-023-08058-6
Article PubMed PubMed Central CAS Google Scholar
Jungrungrueng T, Anugulruengkitt S, Lauhasurayotin S, Chiengthong K, Poparn H, Sosothikul D, Techavichit P (2021) The pattern of microorganisms and drug susceptibility in pediatric oncologic patients with febrile neutropenia. J Pathogens 2021:6692827. https://doi.org/10.1155/2021/6692827
Klastersky J, Ameye L, Maertens J, Georgala A, Muanza F, Aoun M, Ferrant A, Rapoport B, Rolston K, Paesmans M (2007) Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30(Suppl 1):S51–S59. https://doi.org/10.1016/j.ijantimicag.2007.06.012
Article PubMed CAS Google Scholar
Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, Talcott J (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18(16):3038–3051. https://doi.org/10.1200/JCO.2000.18.16.3038
Article PubMed CAS Google Scholar
Koll BS, Brown AE (1993) The changing epidemiology of infections at cancer hospitals. Clin Infect Dis 17(Suppl 2):S322–S328. https://doi.org/10.1093/clinids/17.supplement_2.s322
Lam JC, Chai JY, Wong YL, Tan NW, Ha CT, Chan MY, Tan AM (2015) Causative pathogens of febrile neutropaenia in children treated for acute lymphoblastic leukaemia. Ann Acad Med Singap 44(11):530–534
Lanzkowsky P (2005) Manual Of Pediatric Hematology And Oncology 4th Ed. Elsevier Inc.
Lee D-G, Kim S-H, Kim SY, Kim C-J, Park WB, Song YG, Choi J-H (2011) Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Internal Med 26(2):220–252. https://doi.org/10.3904/kjim.2011.26.2.220
Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Klingebiel T, Creutzig U (2004) Leukemia 18(1):72–77. https://doi.org/10.1038/sj.leu.2403188
Meidani M, Bagheri A, Khorvash F (2013) A Population-Based Study of Bacterial Spectrum in Febrile Neutropenic Patients. Jundishapur J Microbiol 6:150–156
Moon H, Choi YJ, Sim SH (2018) Validation of the clinical index of stable febrile neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department. Can it guide emergency physicians to a reasonable decision on outpatient vs. inpatient treatment? PloS One 13(12):e0210019. https://doi.org/10.1371/journal.pone.0210019
Article PubMed PubMed Central Google Scholar
Oude Nijhuis CSM, Daenen SMGJ, Vellenga E, van der Graaf WTA, Gietema JA, Groen HJM, Kamps WA, de Bont ESJM (2002) Fever and neutropenia in cancer patients: the diagnostic role of cytokines in risk assessment strategies. Crit Rev Oncol Hematol 44(2):163–174. https://doi.org/10.1016/s1040-8428(01)00220-7
Article PubMed CAS Google Scholar
Özdemir ZC, Koç A, Ayçiçek A (2016) Microorganisms isolated from cultures and infection focus and antibiotic treatments in febrile neutropenic children from Şanlıurfa, Turkey. Turk J Pediatr 58(1):47–53. https://doi.org/10.24953/turkjped.2016.01.007
Parodi RL, Lagrutta M, Tortolo M, Navall E, Rodríguez MS, Sasia GF, De Candia LF, Gruvman MA, Bottasso O, Greca AA (2019) A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period. PLoS One 14(10):e0224299. https://doi.org/10.1371/journal.pone.0224299
Article PubMed PubMed Central CAS Google Scholar
Rabayah R, Alsayed RB, Taha AA, Salameh H, Amer R, Sabateen A, Aiesh BM, Zyoud SH (2022) Microbial spectrum and drug resistance profile in solid malignancies in a large tertiary hospital from Palestine. BMC Infect Dis 22(1):385. https://doi.org/10.1186/s12879-022-07375-6
Article PubMed PubMed Central CAS Google Scholar
Santolaya ME, Alvarez AM, Becker A, Cofré J, Enríquez N, O’Ryan M, Payá E, Pilorget J, Salgado C, Tordecilla J, Varas M, Villarroel M, Viviani T, Zubieta M (2001) Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 19(14):3415–3421. https://doi.org/10.1200/JCO.2001.19.14.3415
Article PubMed CAS Google Scholar
Santolaya ME, Alvarez AM, Avilés CL, Becker A, Mosso C, O’Ryan M, Payá E, Salgado C, Silva P, Topelberg S, Tordecilla J, Varas M, Villarroel M, Viviani T, Zubieta M (2007) Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode. Pediatr Infect Dis J 26(9):794–798. https://doi.org/10.1097/INF.0b013e318124aa44
Sereeaphinan C, Kanchanasuwan S, Julamanee J (2021) Mortality-associated clinical risk factors in patients with febrile neutropenia: a retrospective study. IJID Regions 1:5–11. https://doi.org/10.1016/j.ijregi.2021.09.002
Article PubMed PubMed Central Google Scholar
Taj M, Farzana T, Shah T, Maqsood S, Ahmed SS, Shamsi TS (2015) Clinical and microbiological profile of pathogens in febrile neutropenia in hematological malignancies: a single center prospective analysis. J Oncol 2015:596504. https://doi.org/10.1155/2015/596504
留言 (0)